SAN FRANCISCO, (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on ...
HealthEquity management will host a conference call for investors on Tuesday, November 12, 2024, at 4:30 p.m. Eastern Time during which management will discuss the transition and succession plan.
The Last Dance, and after passing $400 million worldwide, the threequel is on track to eventually earn more than 2021's Venom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback